Avalere Health
An Inovalon Company

Market Access and Reimbursement

Optimize Access and Adoption

Today, an expanded universe of stakeholders are defining and evaluating the value of medical interventions beyond the requirements for FDA approval. Payers and providers develop utilization management strategies, including clinical pathways, appropriate use criteria, and bundled payments, to deliver value to the marketplace. Manufacturers also address evolving definitions of value by integrating customer needs and working with guideline and measure developers to ensure health outcome goals are met. Avalere looks at this complex world of commercialization through a single, yet multi-dimensional lens. We draw from policy expertise, private and public payer perspectives, patient and provider requirements, as well as a multitude of other stakeholders to create one integrated market strategy. Specifically, Avalere uses The Payer Edge®, our proprietary network of payer decision makers to inform your coverage and access action plan. From launching new technologies to navigating access challenges for existing products, we help you secure reimbursement and access.

What's Your Challenge?

  • Public and private payer landscape analysis
  • Distributor and specialty pharmacy strategies
  • Reimbursement tools: coding, pricing, contracting
  • Patient support services
  • Field team design and deployment strategy​

Complementary Products


Meet a few of our experts ready to partner with you.

All Staff

Reginald Williams

Senior Vice President


Reginald Williams, Senior Vice President, leads teams that deliver research, analytic, and strategic support to clients, with a focus on the needs of life sciences manufacturers and patient groups. He advises clients on medical technology policy, regulatory and market access strategies for new products, and the evolution of public and private payers' use of evidence for formulating coverage and reimbursement decisions, with a focus on the Medicare program.

Prior to joining Avalere, Reggie was a member of the health policy team at the National Academy of Social Insurance (NASI).He also served as the Howard R. Swearer Public Service intern in the Rhode Island Department of Health's Office of Minority Health.

Reggie has an AB in Biomedical Ethics from Brown University. He also serves on the board of directors of Mental Health America, a nonprofit dedicated to helping people live mentally healthier lives. He is a Patient-Centered Outcomes Research grant reviewer and a member of NASI and Health Technology Assessment International.

Kunal Joshi

Senior Associate


Kunal Joshi, Senior Associate, supports clients on market access, product commercialization, and reimbursement policy. He utilizes his background in pediatric oncology regulatory programs, incentive programs, and medical sciences to maximize product access and improve healthcare delivery.

Prior to joining Avalere, Kunal was Director of Operations and Research at Kids v Cancer, performing necessary research on newly developed drugs, FDA policies, and the drug development process. In addition, he managed operations and developed program content. He has experience as a Research Assistant at the Feinberg Cardiovascular Research Institute.

Kunal earned an MS in Biophysics and Physiology from Georgetown University and a BA from Northwestern University.

Geoffrey Storchan

Senior Manager


Geoffrey Storchan, Senior Manager, advises clients on reimbursement, policy and market access strategies for diagnostics, medical devices and pharmaceuticals companies. Geoffrey also has special expertise in the areas of oncology and endocrinology.

Prior to joining Avalere, Geoffrey was a Postdoctoral Fellow at the National Institutes of Health, contributing to studies on finding new targets and drugs for endocrine therapies. As a graduate student at Georgetown University, Geoffrey conducted research investigating the molecular mechanisms underlying breast cancer progression.

Geoffrey holds a BS in Biology from the University of Michigan and a MS and PhD from Georgetown University in Biochemistry and Molecular Biology.

« Back to Mobile Site